Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Papers: 5 Feb 2016 - 12 Feb 2016
Health Care Utilization and Costs of Medicaid Program Services for Patients Diagnosed with Multiple Sclerosis.
High-resolution characterisation of the aging brain using simultaneous quantitative susceptibility mapping (QSM) and R2* measurements at 7T.
Multiple sclerosis: Bigger brains resist disability in MS.
Hippocampal expressions of metallothionein I/II and glycoprotein 96 in EAE-prone and EAE-resistant strains of rats.
Efficacy of hematopoietic stem cell formultiple sclerosis, an evidence based meta-analysis.
Evaluation of quality of life in individuals with severe chronic motor disability: A major challenge.
Determinants of High Cost in Multiple Sclerosis Patients: A Claims and Chart Review Study.
A rare case of SPG11 mutation with multiple sclerosis.
MS Research Roundup: January 15, 2014
AAN Review Supports Treating Symptoms of MS with Cannabis
Multidisciplinary rehabilitation and steroids in the management of multiple sclerosis relapses: a randomized controlled trial.
The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D.
Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells.
Factors Associated with Caregiver's Burden in Relapsing-Remitting Multiple Sclerosis and Satisfaction with Current Therapies. MS-Feeling Study.
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis.
A New MS Journal
JC Polyomavirus Abundance and Distribution in Progressive Multifocal Leukoencephalopathy (PML) Brain Tissue Implicates Myelin Sheath in Intracerebral Dissemination of Infection.
Understanding walking activity in multiple sclerosis: step count, walking intensity and uninterrupted walking activity duration related to degree of disability.
Patterns of Use of Tests to Monitor Disease Activity Among Patients With Relapsing Remitting Multiple Sclerosis in the United States and Europe.
All relapsing multiple sclerosis patients should be seen in specialist clinics - NO.
A triple-effect cocktail produced by neural stem cells as a novel neurorepair therapy for chronic stage CNS autoimmunity.
All relapsing multiple sclerosis patients should be managed at a specialist clinic - Commentary.
Caveolin-1 Is Critical for Lymphocyte Trafficking into Central Nervous System during Experimental Autoimmune Encephalomyelitis.
Prescribed psychiatric medication among multiple sclerosis patients before and after disability pension: a register study with matched controls.

Pages